Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

Recruiting now

Conditions studied: Parkinsons Disease (PD)

In brief

This study seeks to understand the prevalence and variability of a gut bacteria gene called csgA in people with Parkinson's Disease. This understanding could inform development of potential new therapies targeting the gut in Parkinson's Disease.

Key facts

Study ID
NCT07175922
Run by
Vertero Therapeutics
People needed
200
Starts
2025-09-25
Expected to finish
2026-03-30
Last updated by the study team
2026-02-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.